Surendran, Praveen
Stewart, Isobel D.
Au Yeung, Victoria P. W.
Pietzner, Maik http://orcid.org/0000-0003-3437-9963
Raffler, Johannes
Wörheide, Maria A. http://orcid.org/0000-0002-9326-7227
Li, Chen
Smith, Rebecca F.
Wittemans, Laura B. L.
Bomba, Lorenzo
Menni, Cristina http://orcid.org/0000-0001-9790-0571
Zierer, Jonas http://orcid.org/0000-0002-9693-1859
Rossi, Niccolò
Sheridan, Patricia A.
Watkins, Nicholas A.
Mangino, Massimo http://orcid.org/0000-0002-2167-7470
Hysi, Pirro G.
Di Angelantonio, Emanuele
Falchi, Mario http://orcid.org/0000-0002-5646-1004
Spector, Tim D. http://orcid.org/0000-0002-9795-0365
Soranzo, Nicole http://orcid.org/0000-0003-1095-3852
Michelotti, Gregory A. http://orcid.org/0000-0002-3936-4675
Arlt, Wiebke http://orcid.org/0000-0001-5106-9719
Lotta, Luca A.
Denaxas, Spiros
Hemingway, Harry
Gamazon, Eric R.
Howson, Joanna M. M. http://orcid.org/0000-0001-7618-0050
Wood, Angela M.
Danesh, John
Wareham, Nicholas J. http://orcid.org/0000-0003-1422-2993
Kastenmüller, Gabi http://orcid.org/0000-0002-2368-7322
Fauman, Eric B. http://orcid.org/0000-0002-9739-0249
Suhre, Karsten
Butterworth, Adam S. http://orcid.org/0000-0002-6915-9015
Langenberg, Claudia http://orcid.org/0000-0002-5017-7344
Article History
Received: 10 December 2021
Accepted: 16 September 2022
First Online: 10 November 2022
Competing interests
: During the course of the project, P.S. became a full-time employee of GlaxoSmithKline, V.P.W.A. became a full-time employee of AstraZeneca, L.B. became a full-time employee of BioMarin, J.Z. became a full-time employee of Novartis, J.M.M.H. became a full-time employee of Novo Nordisk Ltd. and L.A.L. is presently an employee and owns stocks and stock options of Regeneron Pharmaceuticals Inc. E.R.G. receives an honorarium from the journal <i>Circulation Research</i> of the American Heart Association, as a member of the Editorial Board. P.A.S. and G.A.M. are employees of Metabolon. T.D.S. is co-founder of Zoe Global Ltd. E.B.F. is an employee of Pfizer. J.D. reports grants, personal fees and non-financial support from Merck Sharp & Dohme (MSD), grants, personal fees and non-financial support from Novartis, grants from Pfizer and grants from AstraZeneca outside the submitted work. J.D. sits on the International Cardiovascular and Metabolic Advisory Board for Novartis (since 2010); the Steering Committee of UK Biobank (since 2011); the MRC International Advisory Group (ING), member, London (since 2013); the MRC High Throughput Science ‘Omics, panel member, London (since 2013); the Scientific Advisory Committee for Sanofi (since 2013); the International Cardiovascular and Metabolism Research and Development Portfolio Committee for Novartis; and the AstraZeneca Genomics Advisory Board (2018). A.S.B. has received grants unrelated to this work from AstraZeneca, Biogen, BioMarin, Bioverativ, Merck, Novartis and Sanofi. The remaining authors declare no competing interests.